Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Dow jumps 240 points after Trump-Japan deal; retail traders fuel meme stock gains while Tesla and Alphabet earnings loom on the trading radar.